Inspire delays $8 mln payment to Spain's Faes

(Reuters) - The move was based on feedback from the U.S. Food and Drug
Administration, Inspire said.




"Inspire will have no financial obligations for the oral
program while Faes is conducting the additional clinical work.


Read more at Reuters.com Government Filings News